Condition: Gynecological Malignancies · Cervical Cancer · Endometrial Cancer · Sponsor: University Hospital Tuebingen
ICK-Gyn is a prospective, multicentric, non-interventional investigator-initiated trial (IIT) that aims to investigate the prognostic value of CRP kinetics in advanced or metastatic gynecological malignancies under immune checkpoint inhibitor (ICI) therapy on the objective response rate (ORR), progression-free survival (PFS) and overall survival (OS).
This description comes directly from the study's public registry record.
Dominik Dannehl, Dr. · 07071 29 82211 · Dominik.Dannehl@med.uni-tuebingen.de
Always discuss trial participation with your own doctor first.
| Department of Women's Health | Tübingen, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05914974